nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Eyelid irritation—Bimatoprost—glaucoma	0.0403	0.0477	CcSEcCtD
Adapalene—Eyelid irritation—Dorzolamide—glaucoma	0.0341	0.0404	CcSEcCtD
Adapalene—Eyelid irritation—Travoprost—glaucoma	0.034	0.0402	CcSEcCtD
Adapalene—Eyelids pruritus—Bimatoprost—glaucoma	0.0268	0.0317	CcSEcCtD
Adapalene—Skin discomfort—Brimonidine—glaucoma	0.0258	0.0306	CcSEcCtD
Adapalene—Eyelids pruritus—Brimonidine—glaucoma	0.0237	0.0281	CcSEcCtD
Adapalene—Eyelids pruritus—Travoprost—glaucoma	0.0226	0.0267	CcSEcCtD
Adapalene—Eyelids pruritus—Brinzolamide—glaucoma	0.0223	0.0264	CcSEcCtD
Adapalene—Erythema of eyelid—Apraclonidine—glaucoma	0.019	0.0225	CcSEcCtD
Adapalene—Erythema of eyelid—Bimatoprost—glaucoma	0.0184	0.0218	CcSEcCtD
Adapalene—Erythema of eyelid—Brimonidine—glaucoma	0.0163	0.0193	CcSEcCtD
Adapalene—Erythema of eyelid—Dorzolamide—glaucoma	0.0156	0.0184	CcSEcCtD
Adapalene—Erythema of eyelid—Travoprost—glaucoma	0.0155	0.0183	CcSEcCtD
Adapalene—Keratoconjunctivitis—Brinzolamide—glaucoma	0.0153	0.0181	CcSEcCtD
Adapalene—Erythema of eyelid—Brinzolamide—glaucoma	0.0153	0.0181	CcSEcCtD
Adapalene—Pain of skin—Brimonidine—glaucoma	0.0126	0.015	CcSEcCtD
Adapalene—Eyelids pruritus—Timolol—glaucoma	0.0122	0.0144	CcSEcCtD
Adapalene—Redness—Echothiophate—glaucoma	0.0118	0.014	CcSEcCtD
Adapalene—Stinging—Dipivefrin—glaucoma	0.0117	0.0139	CcSEcCtD
Adapalene—Erythema of eyelid—Betaxolol—glaucoma	0.0102	0.0121	CcSEcCtD
Adapalene—Stinging—Echothiophate—glaucoma	0.00983	0.0116	CcSEcCtD
Adapalene—Eyelid oedema—Latanoprost—glaucoma	0.00859	0.0102	CcSEcCtD
Adapalene—Erythema of eyelid—Timolol—glaucoma	0.00835	0.00989	CcSEcCtD
Adapalene—Keratitis—Carteolol—glaucoma	0.00763	0.00903	CcSEcCtD
Adapalene—Keratitis—Levobunolol—glaucoma	0.00721	0.00853	CcSEcCtD
Adapalene—Excoriation—Clonidine—glaucoma	0.0071	0.00841	CcSEcCtD
Adapalene—Skin irritation—Brimonidine—glaucoma	0.00688	0.00815	CcSEcCtD
Adapalene—Eyelid oedema—Apraclonidine—glaucoma	0.00687	0.00813	CcSEcCtD
Adapalene—Keratitis—Latanoprost—glaucoma	0.00669	0.00791	CcSEcCtD
Adapalene—Eyelid oedema—Bimatoprost—glaucoma	0.00666	0.00788	CcSEcCtD
Adapalene—Instillation site pain—Clonidine—glaucoma	0.00658	0.00779	CcSEcCtD
Adapalene—Skin irritation—Dorzolamide—glaucoma	0.00657	0.00778	CcSEcCtD
Adapalene—Eyelid oedema—Brimonidine—glaucoma	0.0059	0.00698	CcSEcCtD
Adapalene—Stinging—Carbachol—glaucoma	0.00586	0.00694	CcSEcCtD
Adapalene—Dermatitis atopic—Latanoprost—glaucoma	0.00586	0.00694	CcSEcCtD
Adapalene—Stinging—Levobunolol—glaucoma	0.00577	0.00683	CcSEcCtD
Adapalene—Eyelid oedema—Dorzolamide—glaucoma	0.00563	0.00667	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00562	0.0362	CbGpPWpGaD
Adapalene—Eyelid oedema—Travoprost—glaucoma	0.00561	0.00664	CcSEcCtD
Adapalene—Eyelid oedema—Brinzolamide—glaucoma	0.00554	0.00655	CcSEcCtD
Adapalene—Stinging—Latanoprost—glaucoma	0.00535	0.00634	CcSEcCtD
Adapalene—Keratitis—Apraclonidine—glaucoma	0.00534	0.00633	CcSEcCtD
Adapalene—Keratitis—Bimatoprost—glaucoma	0.00518	0.00613	CcSEcCtD
Adapalene—Conjunctivitis—Dipivefrin—glaucoma	0.00517	0.00612	CcSEcCtD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00514	0.0331	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00504	0.0324	CbGpPWpGaD
Adapalene—Application site pain—Clonidine—glaucoma	0.00488	0.00577	CcSEcCtD
Adapalene—Burning sensation—Bimatoprost—glaucoma	0.00484	0.00573	CcSEcCtD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00483	0.0311	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00483	0.0311	CbGpPWpGaD
Adapalene—Vesiculobullous rash—Pilocarpine—glaucoma	0.00479	0.00567	CcSEcCtD
Adapalene—Keratitis—Brimonidine—glaucoma	0.00459	0.00543	CcSEcCtD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00453	0.0292	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00447	0.0288	CbGpPWpGaD
Adapalene—Keratitis—Dorzolamide—glaucoma	0.00438	0.00519	CcSEcCtD
Adapalene—Keratitis—Travoprost—glaucoma	0.00436	0.00517	CcSEcCtD
Adapalene—Keratitis—Brinzolamide—glaucoma	0.00431	0.0051	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00428	0.0276	CbGpPWpGaD
Adapalene—Burning sensation—Brimonidine—glaucoma	0.00428	0.00507	CcSEcCtD
Adapalene—Convulsion—Physostigmine—glaucoma	0.00423	0.00501	CcSEcCtD
Adapalene—Redness—Dorzolamide—glaucoma	0.00421	0.00498	CcSEcCtD
Adapalene—Stinging—Bimatoprost—glaucoma	0.00415	0.00491	CcSEcCtD
Adapalene—Keratitis—Pilocarpine—glaucoma	0.00414	0.0049	CcSEcCtD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00406	0.0262	CbGpPWpGaD
Adapalene—Seborrhoeic dermatitis—Pilocarpine—glaucoma	0.00394	0.00466	CcSEcCtD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.0039	0.0251	CbGpPWpGaD
Adapalene—Dermatitis atopic—Travoprost—glaucoma	0.00382	0.00453	CcSEcCtD
Adapalene—Feeling hot—Brimonidine—glaucoma	0.00379	0.00449	CcSEcCtD
Adapalene—Skin discolouration—Bimatoprost—glaucoma	0.00372	0.00441	CcSEcCtD
Adapalene—Stinging—Brimonidine—glaucoma	0.00367	0.00435	CcSEcCtD
Adapalene—Skin irritation—Timolol—glaucoma	0.00353	0.00418	CcSEcCtD
Adapalene—Stinging—Dorzolamide—glaucoma	0.00351	0.00415	CcSEcCtD
Adapalene—Eczema—Latanoprost—glaucoma	0.0035	0.00415	CcSEcCtD
Adapalene—Eye pain—Latanoprost—glaucoma	0.00349	0.00413	CcSEcCtD
Adapalene—Erythema—Echothiophate—glaucoma	0.00348	0.00412	CcSEcCtD
Adapalene—Dermatitis contact—Apraclonidine—glaucoma	0.00343	0.00406	CcSEcCtD
Adapalene—Rash pustular—Pilocarpine—glaucoma	0.00337	0.00399	CcSEcCtD
Adapalene—Stinging—Pilocarpine—glaucoma	0.00331	0.00392	CcSEcCtD
Adapalene—Skin discolouration—Travoprost—glaucoma	0.00313	0.00371	CcSEcCtD
Adapalene—Herpes simplex—Travoprost—glaucoma	0.00307	0.00364	CcSEcCtD
Adapalene—RARG—Nuclear Receptors—NR3C1—glaucoma	0.00307	0.0197	CbGpPWpGaD
Adapalene—Eyelid oedema—Timolol—glaucoma	0.00302	0.00358	CcSEcCtD
Adapalene—Dermatitis contact—Brimonidine—glaucoma	0.00294	0.00348	CcSEcCtD
Adapalene—Herpes simplex—Pilocarpine—glaucoma	0.00291	0.00345	CcSEcCtD
Adapalene—Conjunctivitis—Metipranolol—glaucoma	0.0029	0.00344	CcSEcCtD
Adapalene—Pain—Dipivefrin—glaucoma	0.0029	0.00343	CcSEcCtD
Adapalene—Keratitis—Betaxolol—glaucoma	0.00288	0.00341	CcSEcCtD
Adapalene—Dermatitis contact—Dorzolamide—glaucoma	0.00281	0.00333	CcSEcCtD
Adapalene—RXRG—Nuclear Receptors—NR3C1—glaucoma	0.0028	0.0181	CbGpPWpGaD
Adapalene—Dermatitis contact—Travoprost—glaucoma	0.0028	0.00331	CcSEcCtD
Adapalene—Eye pain—Apraclonidine—glaucoma	0.00279	0.0033	CcSEcCtD
Adapalene—RXRA—Endogenous sterols—CYP1B1—glaucoma	0.00278	0.0179	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—NR3C1—glaucoma	0.00275	0.0177	CbGpPWpGaD
Adapalene—Eye pain—Bimatoprost—glaucoma	0.0027	0.0032	CcSEcCtD
Adapalene—Conjunctivitis—Carteolol—glaucoma	0.00269	0.00319	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.00266	0.0171	CbGpPWpGaD
Adapalene—Dermatitis contact—Pilocarpine—glaucoma	0.00265	0.00314	CcSEcCtD
Adapalene—RARA—Nuclear Receptors—NR3C1—glaucoma	0.00264	0.017	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—NR3C1—glaucoma	0.00264	0.017	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Methazolamide—glaucoma	0.00257	0.00304	CcSEcCtD
Adapalene—Conjunctivitis—Levobunolol—glaucoma	0.00254	0.00301	CcSEcCtD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00252	0.0162	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.0025	0.0161	CbGpPWpGaD
Adapalene—Hypersensitivity—Dipivefrin—glaucoma	0.0025	0.00296	CcSEcCtD
Adapalene—Pain—Echothiophate—glaucoma	0.00243	0.00288	CcSEcCtD
Adapalene—Face oedema—Apraclonidine—glaucoma	0.00243	0.00288	CcSEcCtD
Adapalene—RARG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00242	0.0156	CbGpPWpGaD
Adapalene—Eye pain—Brimonidine—glaucoma	0.00239	0.00283	CcSEcCtD
Adapalene—Conjunctivitis—Latanoprost—glaucoma	0.00236	0.00279	CcSEcCtD
Adapalene—Keratitis—Timolol—glaucoma	0.00235	0.00278	CcSEcCtD
Adapalene—Eye pain—Dorzolamide—glaucoma	0.00229	0.00271	CcSEcCtD
Adapalene—Eye pain—Travoprost—glaucoma	0.00228	0.00269	CcSEcCtD
Adapalene—Eye pain—Brinzolamide—glaucoma	0.00225	0.00266	CcSEcCtD
Adapalene—Dry skin—Bimatoprost—glaucoma	0.00224	0.00265	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00223	0.0144	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00222	0.0143	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Dorzolamide—glaucoma	0.00219	0.00259	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00217	0.014	CbGpPWpGaD
Adapalene—Eczema—Pilocarpine—glaucoma	0.00217	0.00257	CcSEcCtD
Adapalene—Eye pain—Pilocarpine—glaucoma	0.00216	0.00256	CcSEcCtD
Adapalene—RXRG—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.00215	0.0138	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—NR3C1—glaucoma	0.00213	0.0137	CbGpPWpGaD
Adapalene—Dermatitis contact—Clonidine—glaucoma	0.00212	0.00251	CcSEcCtD
Adapalene—Face oedema—Brimonidine—glaucoma	0.00209	0.00247	CcSEcCtD
Adapalene—RXRB—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00208	0.0134	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00208	0.0134	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Pilocarpine—glaucoma	0.00207	0.00245	CcSEcCtD
Adapalene—Dermatitis bullous—Pilocarpine—glaucoma	0.00204	0.00241	CcSEcCtD
Adapalene—RXRB—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.00202	0.013	CbGpPWpGaD
Adapalene—Dry skin—Brimonidine—glaucoma	0.00198	0.00234	CcSEcCtD
Adapalene—Erythema—Latanoprost—glaucoma	0.0019	0.00224	CcSEcCtD
Adapalene—Conjunctivitis—Apraclonidine—glaucoma	0.00188	0.00223	CcSEcCtD
Adapalene—Stinging—Timolol—glaucoma	0.00188	0.00223	CcSEcCtD
Adapalene—Face oedema—Pilocarpine—glaucoma	0.00188	0.00223	CcSEcCtD
Adapalene—Dry skin—Pilocarpine—glaucoma	0.00179	0.00212	CcSEcCtD
Adapalene—Photosensitivity reaction—Acetazolamide—glaucoma	0.00178	0.0021	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00171	0.011	CbGpPWpGaD
Adapalene—Convulsion—Methazolamide—glaucoma	0.0017	0.00201	CcSEcCtD
Adapalene—Conjunctivitis—Brimonidine—glaucoma	0.00162	0.00192	CcSEcCtD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00156	0.0101	CbGpPWpGaD
Adapalene—Conjunctivitis—Dorzolamide—glaucoma	0.00155	0.00183	CcSEcCtD
Adapalene—Conjunctivitis—Travoprost—glaucoma	0.00154	0.00182	CcSEcCtD
Adapalene—Photosensitivity reaction—Pilocarpine—glaucoma	0.00154	0.00182	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00153	0.00987	CbGpPWpGaD
Adapalene—Conjunctivitis—Brinzolamide—glaucoma	0.00152	0.0018	CcSEcCtD
Adapalene—Erythema—Apraclonidine—glaucoma	0.00152	0.00179	CcSEcCtD
Adapalene—Eczema—Betaxolol—glaucoma	0.00151	0.00179	CcSEcCtD
Adapalene—Eye pain—Betaxolol—glaucoma	0.0015	0.00178	CcSEcCtD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00147	0.00946	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.00147	0.00946	CbGpPWpGaD
Adapalene—Erythema—Bimatoprost—glaucoma	0.00147	0.00174	CcSEcCtD
Adapalene—Conjunctivitis—Pilocarpine—glaucoma	0.00146	0.00173	CcSEcCtD
Adapalene—Pain—Carbachol—glaucoma	0.00145	0.00172	CcSEcCtD
Adapalene—Pain—Levobunolol—glaucoma	0.00143	0.00169	CcSEcCtD
Adapalene—Hypersensitivity—Metipranolol—glaucoma	0.0014	0.00166	CcSEcCtD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—glaucoma	0.0014	0.00904	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—NR3C1—glaucoma	0.00137	0.00885	CbGpPWpGaD
Adapalene—Hepatitis—Pilocarpine—glaucoma	0.00135	0.0016	CcSEcCtD
Adapalene—Urticaria—Levobunolol—glaucoma	0.00133	0.00157	CcSEcCtD
Adapalene—Pain—Latanoprost—glaucoma	0.00132	0.00157	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.0013	0.0084	CbGpPWpGaD
Adapalene—Erythema—Brimonidine—glaucoma	0.0013	0.00154	CcSEcCtD
Adapalene—Hypersensitivity—Carteolol—glaucoma	0.0013	0.00154	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00129	0.0083	CbGpPWpGaD
Adapalene—Urticaria—Methazolamide—glaucoma	0.00127	0.0015	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00125	0.00807	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SLC6A13—glaucoma	0.00125	0.00803	CbGpPWpGaD
Adapalene—Erythema—Dorzolamide—glaucoma	0.00124	0.00147	CcSEcCtD
Adapalene—Erythema—Travoprost—glaucoma	0.00124	0.00146	CcSEcCtD
Adapalene—Hypersensitivity—Levobunolol—glaucoma	0.00123	0.00146	CcSEcCtD
Adapalene—Pruritus—Diclofenamide—glaucoma	0.00123	0.00145	CcSEcCtD
Adapalene—Eye pain—Timolol—glaucoma	0.00123	0.00145	CcSEcCtD
Adapalene—Erythema—Brinzolamide—glaucoma	0.00122	0.00145	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.0012	0.00774	CbGpPWpGaD
Adapalene—Rash—Metipranolol—glaucoma	0.0012	0.00142	CcSEcCtD
Adapalene—Dermatitis—Metipranolol—glaucoma	0.0012	0.00142	CcSEcCtD
Adapalene—Pruritus—Levobunolol—glaucoma	0.00118	0.0014	CcSEcCtD
Adapalene—Convulsion—Acetazolamide—glaucoma	0.00117	0.00139	CcSEcCtD
Adapalene—Dermatitis exfoliative—Timolol—glaucoma	0.00117	0.00139	CcSEcCtD
Adapalene—Angioedema—Dorzolamide—glaucoma	0.00114	0.00134	CcSEcCtD
Adapalene—Pruritus—Latanoprost—glaucoma	0.00109	0.0013	CcSEcCtD
Adapalene—Rash—Diclofenamide—glaucoma	0.00109	0.0013	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00109	0.00699	CbGpPWpGaD
Adapalene—Hepatitis—Clonidine—glaucoma	0.00108	0.00128	CcSEcCtD
Adapalene—Rash—Carbachol—glaucoma	0.00107	0.00126	CcSEcCtD
Adapalene—Dermatitis—Carbachol—glaucoma	0.00107	0.00126	CcSEcCtD
Adapalene—Pain—Apraclonidine—glaucoma	0.00106	0.00125	CcSEcCtD
Adapalene—RXRA—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.00105	0.00678	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—NR3C1—glaucoma	0.00105	0.00675	CbGpPWpGaD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00105	0.00673	CbGpPWpGaD
Adapalene—Pain—Bimatoprost—glaucoma	0.00103	0.00121	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—TXN—glaucoma	0.00102	0.0066	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—NR3C1—glaucoma	0.00102	0.00658	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—FAS—glaucoma	0.00102	0.00654	CbGpPWpGaD
Adapalene—Conjunctivitis—Betaxolol—glaucoma	0.00102	0.0012	CcSEcCtD
Adapalene—Rash—Methazolamide—glaucoma	0.00101	0.00119	CcSEcCtD
Adapalene—Dermatitis—Methazolamide—glaucoma	0.00101	0.00119	CcSEcCtD
Adapalene—RARA—Adipogenesis—NR3C1—glaucoma	0.000986	0.00635	CbGpPWpGaD
Adapalene—Rash—Latanoprost—glaucoma	0.000975	0.00115	CcSEcCtD
Adapalene—Dermatitis—Latanoprost—glaucoma	0.000975	0.00115	CcSEcCtD
Adapalene—RARA—Adipogenesis—FAS—glaucoma	0.000955	0.00615	CbGpPWpGaD
Adapalene—Erythema—Clonidine—glaucoma	0.000938	0.00111	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000935	0.00602	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SLC6A1—glaucoma	0.000913	0.00588	CbGpPWpGaD
Adapalene—Hypersensitivity—Apraclonidine—glaucoma	0.000911	0.00108	CcSEcCtD
Adapalene—Pain—Brimonidine—glaucoma	0.000908	0.00107	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000896	0.00577	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—PEX19—glaucoma	0.000887	0.00571	CbGpPWpGaD
Adapalene—Urticaria—Acetazolamide—glaucoma	0.000879	0.00104	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000875	0.00564	CbGpPWpGaD
Adapalene—Pruritus—Apraclonidine—glaucoma	0.000875	0.00104	CcSEcCtD
Adapalene—Pain—Dorzolamide—glaucoma	0.000867	0.00103	CcSEcCtD
Adapalene—Pain—Travoprost—glaucoma	0.000863	0.00102	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000861	0.00554	CbGpPWpGaD
Adapalene—Angioedema—Clonidine—glaucoma	0.000857	0.00101	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000856	0.00551	CbGpPWpGaD
Adapalene—Pain—Brinzolamide—glaucoma	0.000852	0.00101	CcSEcCtD
Adapalene—Pruritus—Bimatoprost—glaucoma	0.000848	0.001	CcSEcCtD
Adapalene—Conjunctivitis—Timolol—glaucoma	0.000829	0.000982	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000826	0.00532	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00082	0.00528	CbGpPWpGaD
Adapalene—Pain—Pilocarpine—glaucoma	0.000819	0.00097	CcSEcCtD
Adapalene—Erythema—Betaxolol—glaucoma	0.000816	0.000966	CcSEcCtD
Adapalene—Urticaria—Dorzolamide—glaucoma	0.000806	0.000954	CcSEcCtD
Adapalene—RXRA—PPARA activates gene expression—ABCA1—glaucoma	0.000794	0.00511	CbGpPWpGaD
Adapalene—Urticaria—Brinzolamide—glaucoma	0.000792	0.000938	CcSEcCtD
Adapalene—Hypersensitivity—Brimonidine—glaucoma	0.000782	0.000926	CcSEcCtD
Adapalene—Dermatitis—Apraclonidine—glaucoma	0.000779	0.000922	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000777	0.005	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000766	0.00493	CbGpPWpGaD
Adapalene—Rash—Bimatoprost—glaucoma	0.000756	0.000895	CcSEcCtD
Adapalene—Dermatitis—Bimatoprost—glaucoma	0.000755	0.000894	CcSEcCtD
Adapalene—Pruritus—Brimonidine—glaucoma	0.000751	0.000889	CcSEcCtD
Adapalene—Hypersensitivity—Dorzolamide—glaucoma	0.000747	0.000884	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—TGFB2—glaucoma	0.000744	0.00479	CbGpPWpGaD
Adapalene—Hypersensitivity—Travoprost—glaucoma	0.000744	0.000881	CcSEcCtD
Adapalene—Hypersensitivity—Brinzolamide—glaucoma	0.000734	0.00087	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000732	0.00471	CbGpPWpGaD
Adapalene—Pruritus—Dorzolamide—glaucoma	0.000717	0.000849	CcSEcCtD
Adapalene—Pruritus—Travoprost—glaucoma	0.000714	0.000846	CcSEcCtD
Adapalene—Hypersensitivity—Pilocarpine—glaucoma	0.000706	0.000836	CcSEcCtD
Adapalene—Pruritus—Brinzolamide—glaucoma	0.000705	0.000835	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000702	0.00452	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTT1—glaucoma	0.000697	0.00449	CbGpPWpGaD
Adapalene—Pruritus—Pilocarpine—glaucoma	0.000678	0.000803	CcSEcCtD
Adapalene—Rash—Brimonidine—glaucoma	0.000669	0.000793	CcSEcCtD
Adapalene—Dermatitis—Brimonidine—glaucoma	0.000669	0.000792	CcSEcCtD
Adapalene—Erythema—Timolol—glaucoma	0.000667	0.000789	CcSEcCtD
Adapalene—Pain—Clonidine—glaucoma	0.000654	0.000775	CcSEcCtD
Adapalene—Rash—Dorzolamide—glaucoma	0.000639	0.000757	CcSEcCtD
Adapalene—Dermatitis—Dorzolamide—glaucoma	0.000639	0.000756	CcSEcCtD
Adapalene—Rash—Travoprost—glaucoma	0.000637	0.000754	CcSEcCtD
Adapalene—Dermatitis—Travoprost—glaucoma	0.000636	0.000753	CcSEcCtD
Adapalene—Rash—Brinzolamide—glaucoma	0.000629	0.000744	CcSEcCtD
Adapalene—Dermatitis—Brinzolamide—glaucoma	0.000628	0.000743	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000626	0.00403	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000626	0.00403	CbGpPWpGaD
Adapalene—Angioedema—Timolol—glaucoma	0.000609	0.000721	CcSEcCtD
Adapalene—Urticaria—Clonidine—glaucoma	0.000608	0.00072	CcSEcCtD
Adapalene—Rash—Pilocarpine—glaucoma	0.000604	0.000715	CcSEcCtD
Adapalene—Dermatitis—Pilocarpine—glaucoma	0.000604	0.000715	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.0006	0.00387	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000599	0.00386	CbGpPWpGaD
Adapalene—Pain—Betaxolol—glaucoma	0.00057	0.000674	CcSEcCtD
Adapalene—Hypersensitivity—Clonidine—glaucoma	0.000564	0.000667	CcSEcCtD
Adapalene—RXRA—Biological oxidations—CYP1B1—glaucoma	0.000555	0.00357	CbGpPWpGaD
Adapalene—Pruritus—Clonidine—glaucoma	0.000541	0.000641	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000535	0.00345	CbGpPWpGaD
Adapalene—Urticaria—Betaxolol—glaucoma	0.000529	0.000627	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000519	0.00334	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—NR3C1—glaucoma	0.000514	0.00331	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—GSTM1—glaucoma	0.000506	0.00326	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—FAS—glaucoma	0.000498	0.0032	CbGpPWpGaD
Adapalene—Hypersensitivity—Betaxolol—glaucoma	0.000491	0.000581	CcSEcCtD
Adapalene—RXRA—Metabolism—NARFL—glaucoma	0.000488	0.00314	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA5A—glaucoma	0.000488	0.00314	CbGpPWpGaD
Adapalene—Rash—Clonidine—glaucoma	0.000482	0.000571	CcSEcCtD
Adapalene—Dermatitis—Clonidine—glaucoma	0.000482	0.000571	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000477	0.00307	CbGpPWpGaD
Adapalene—Pruritus—Betaxolol—glaucoma	0.000471	0.000558	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000467	0.00301	CbGpPWpGaD
Adapalene—Pain—Timolol—glaucoma	0.000465	0.000551	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000461	0.00296	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTM1—glaucoma	0.000444	0.00286	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000442	0.00284	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NCK2—glaucoma	0.00044	0.00283	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000436	0.00281	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000436	0.00281	CbGpPWpGaD
Adapalene—Urticaria—Timolol—glaucoma	0.000432	0.000512	CcSEcCtD
Adapalene—RXRG—Adipogenesis—TNF—glaucoma	0.000431	0.00278	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00043	0.00277	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—CDKN2B—glaucoma	0.000428	0.00275	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000428	0.00275	CbGpPWpGaD
Adapalene—Rash—Betaxolol—glaucoma	0.00042	0.000497	CcSEcCtD
Adapalene—Dermatitis—Betaxolol—glaucoma	0.00042	0.000497	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—NR3C1—glaucoma	0.000419	0.00269	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000418	0.00269	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—CDKN2B—glaucoma	0.00041	0.00264	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CDKN2B—glaucoma	0.00041	0.00264	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—glaucoma	0.000405	0.00261	CbGpPWpGaD
Adapalene—Hypersensitivity—Timolol—glaucoma	0.000401	0.000475	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.0004	0.00257	CbGpPWpGaD
Adapalene—Pruritus—Timolol—glaucoma	0.000385	0.000456	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—NR3C1—glaucoma	0.000383	0.00246	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—NR3C1—glaucoma	0.000375	0.00242	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000366	0.00236	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000363	0.00234	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—NR3C1—glaucoma	0.00036	0.00232	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—NR3C1—glaucoma	0.00036	0.00232	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000348	0.00224	CbGpPWpGaD
Adapalene—Rash—Timolol—glaucoma	0.000343	0.000406	CcSEcCtD
Adapalene—Dermatitis—Timolol—glaucoma	0.000343	0.000406	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000321	0.00207	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000313	0.00201	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000311	0.002	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000298	0.00192	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000292	0.00188	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PAX6—glaucoma	0.000285	0.00184	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000274	0.00176	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000263	0.00169	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA1—glaucoma	0.000238	0.00154	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CTSA—glaucoma	0.000231	0.00149	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00023	0.00148	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CDKN2B—glaucoma	0.00023	0.00148	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA2—glaucoma	0.000218	0.0014	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000218	0.0014	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CDKN2B—glaucoma	0.000214	0.00138	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000213	0.00137	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000213	0.00137	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—glaucoma	0.000211	0.00136	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CDKN2B—glaucoma	0.00021	0.00135	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CDKN2B—glaucoma	0.000206	0.00133	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NR3C1—glaucoma	0.000202	0.0013	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CDKN2B—glaucoma	0.000197	0.00127	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CDKN2B—glaucoma	0.000197	0.00127	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NR3C1—glaucoma	0.000188	0.00121	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NR3C1—glaucoma	0.000184	0.00119	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000181	0.00117	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NR3C1—glaucoma	0.000181	0.00116	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NR3C1—glaucoma	0.000173	0.00112	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NR3C1—glaucoma	0.000173	0.00112	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000155	0.001	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TXN—glaucoma	0.000154	0.000989	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.00014	0.000903	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000139	0.000894	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000137	0.000882	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP2—glaucoma	0.000126	0.000808	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—glaucoma	0.000119	0.000767	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CDKN2B—glaucoma	0.000103	0.000663	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.61e-05	0.000619	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1B1—glaucoma	9.49e-05	0.000611	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCA1—glaucoma	9.49e-05	0.000611	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—glaucoma	9.44e-05	0.000608	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NR3C1—glaucoma	9.03e-05	0.000581	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—glaucoma	8.47e-05	0.000546	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—glaucoma	7.59e-05	0.000489	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—glaucoma	7.26e-05	0.000468	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—glaucoma	6.71e-05	0.000432	CbGpPWpGaD
Adapalene—RXRA—Metabolism—APOE—glaucoma	6.24e-05	0.000402	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CAV1—glaucoma	6.19e-05	0.000398	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NOS3—glaucoma	4.68e-05	0.000301	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—glaucoma	4.28e-05	0.000275	CbGpPWpGaD
